Novocure (NVCR) Tops Q2 EPS by 6c, Revenues Beat

July 25, 2019 6:16 AM

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found